AWH Aspira Women's Health
- 1.6100
- +0.3400+26.77%
- 1.6400
- +0.0300+1.86%
Aspira Women's Health News
Express News | Aspira Women's Health Shares Are Trading Higher After the Company Announced That Preliminary OvaWatch Volume During Q2 2024 Grew 24% Quarter-over-quarter to 1,307 Units
Aspira Women's Health Announces Preliminary OvaWatch Volume During Q2 2024 Grew 24% QoQ To 1,307 Units; Preliminary OvaSuite Volume During Q2 2024 Grew 11% QoQ To 6,471 Units
Preliminary OvaWatch volume during Q2 2024 grew 24% over the prior quarter to 1,307 unitsPreliminary OvaSuiteSM volume during Q2 2024 grew 11% over the prior quarter to 6,471 unitsAUSTIN, Texas,
Aspira Women's Health Announces Preliminary Second Quarter 2024 OvaSuite Product Volume and Highlights
Preliminary OvaWatch volume during Q2 2024 grew 24% over the prior quarter to 1,307 units Preliminary OvaSuiteSM volume during Q2 2024 grew 11% over the prior quarter to 6,471 units AUSTIN, Texas,
Express News | Aspira Women’s Health Announces Closing of $1.9 Million Private Placement Equity Financing
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersCNS Pharma (NASDAQ:CNSP) stock rose 109.5% to $2.64 during Thursday's pre-market session. The company's market cap stands at $2.2 million. Autonomix Medical (NASDAQ:AMIX) stock moved upwards by
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Powell Speech
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.5% and the actively traded Invesco QQQ Trust (QQQ) was 0.6% lower in Tuesday's premarket activity, as investors await Fede
Express News | Aspira Women's Health Shares Are Trading Higher. The Company Announced a Private Placement Equity Financing of $1.935 Million
Express News | Aspira Women’s Health Announces $1.935 Million Private Placement Equity Financing
Aspira Financial Chief Terminated for Cause; CEO Takes Over on Interim Basis
By Adam L. Cataldo Aspira Women's Health said its chief financial officer has been terminated for cause due to a personal civil matter. The company said in U.S. Securities and Exchange Commission fi
Express News | Aspira Women's Health- as of June 27, 2024, Nicole Sandford Has Taken Over Hombeck’ S Duties on an Interim Basis
Express News | Aspira Women's Health-Compensation Committee Determined Personal Civil Matter Interfered With Torsten Hombeck’s Ability to Continue to Serve as CFO
Insider Buyers At Aspira Women's Health Likely Disappointed With 19% Slide
Express News | Aspira Women's Health Inc: Cash Used in Operations Guidance for 2024 Expected to Be Lowered
Aspira Women's Health Provides Commercial, Reimbursement and Cash Guidance Updates
Monthly OvaSuiteSM product volume grew by more than 26% in May compared to January Reimbursement momentum continued with expanded Anthem and Medicaid coverage for OvaSuite Cash used in operations guid
Aspira Women's Health(AWH.US) Officer Buys US$22,973.06 in Common Stock
$Aspira Women's Health(AWH.US)$ Officer Sandford Nicole purchased 9,493 shares of common stock on May 31, 2024 at an average price of $2.42 for a total value of $22,973.06.Source: Announcement What is
PTC Therapeutics, Oragenics, GT Biopharma Among Healthcare Movers
Aspira Women's Health to Present at the A.G.P. Healthcare Showcase on May 21
AUSTIN, Texas, May 16, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gyne
Aspira Women's Health | 10-Q: Quarterly report
Earnings Call Summary | Aspira Women's Health(AWH.US) Q1 2024 Earnings Conference
The following is a summary of the Aspira Women's Health Inc. (AWH) Q1 2024 Earnings Call Transcript:Financial Performance:Aspira Women's Health reported Q1 2024 revenues of $2.2 million, slightly lowe
Express News | Aspira Women's Health Inc - We Continued Our Two-Year Trend of Cost Reductions Across Company
Analysis
Price Target
No Data
